(Via: www.hear-it.org) Patients treated with aminoglycoside antibiotics are at risk of hearing loss, a study shows
Research conducted at the Oregon Health and Science University School of Medicine in the US shows that the use of aminoglycoside antibiotics poses the greatest risk to patients with inflammatory bacterial infections. The drugs are known to damage the sensory cells in the inner ear that detect sound and motion, because the inflammation that accompanies bacterial infections boosts the uptake of the drug.
Aminoglycoside antibiotics are e.g. used to treat meningitis, bacteremia, respiratory diseases in patients with cystic fibrosis and premature infants with infections in neonatal intensive care.Read More